CompleteMD DME

CompleteMD DME empowers Dermatology practices with the most effective biotechnology solutions to enhance patient care while driving profitable revenue. Our DermDME System makes it effortless & easy to obtain & remain DME compliant while reaping the rewards made available through DME Licensure. DermDME is the 1st & only DME credentialing & support system created by Dermatologists for Dermatologists. Our Collagen Matrix, available through DermDME, dramatically improves secondary granulation outcomes for the patient AND the practice gets paid for it. Through DermDME, dermatologists prescribe our Collagen Matrix, the patient uses the product for post-excision wound healing, & Medicare pays reimbursement, making it more profitable to allow most wounds to granulate secondarily than to perform a close out. Our Collagen Matrix: 1. Is made in USA of 100% pure bovine collagen, free of additives & fillers. 2. Designed to work with the skin’s natural cellular matrix by stimulating fibroblast & macrophage generation which accelerates the healing process. 3. Collagen absorbs 40 times it's weight of fluid, prevents delayed healing, & assists difficult-to-heal & stalling wounds. 4. Fits to the wound: The user or a medical professional creates a paste solution to apply to the wound. Works great for deeper tunnel wounds. 5. 86% of Patients prefer our Collagen Matrix to stitches when given the choice after experiencing both, see study available on website. Patients love the fact they can participate in their own wound healing & return to normal life immediately after surgery with no fear of stitches ripping out or post-op infections because they are using our Collagen Matrix. After using our Collagen products, Dermatologists let most post-excision wounds granulate secondarily, performing close outs only as necessary, because they see the outcomes are as good or better for their patients AND the practice makes 30% to 100% more profitable revenue per excision.

网站

https://cmddme.com/

CompleteMD DME的外部链接

所属行业

医疗设备制造业

规模

11-50 人

总部

Savannah，Georgia

类型

私人持股

创立

2020

领域

Mohs Surgery、Melanoma、Excision procedures、Wound healing和dermatology